Regeneron Pharmaceuticals Inc (BSP:REGN34)
R$ 89.25 1.25 (1.42%) Market Cap: 590.31 Bil Enterprise Value: 549.72 Bil PE Ratio: 24.59 PB Ratio: 3.63 GF Score: 86/100

Regeneron Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 01, 2021 / 01:00PM GMT
Release Date Price: R$60.23
Christopher Joseph Raymond
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Great. Let's go ahead and get started with our next session. Thanks, everybody, for dialing in for the Piper Sandler. This is our 33rd Annual Healthcare Conference. I'm very pleased to have with us our next presenter, which is Regeneron.

Just a little bit of housekeeping for folks. We are obviously doing this virtually and very much hope to get back in-person next year. But for folks who are listening in, if you have any questions, I think there's an option for you on your Zoom app that's opened. If you don't want to do that, you can also just e-mail me, just hit me up on e-mail, and I'll be monitoring that. So we've got 25 minutes. We've got Bob Landry, who's the CFO and also Vesna Tosic, who is the Head of IR function at Regeneron. So I think, Vesna, you're going to have some safe harbor statements, so you go out, take care. And then Bob's got a little bit of an intro, and then we'll dive into questions. So guys, please take it away.

Vesna Tosic

Chris,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot